Overview
Advanced one-year fellowship within Stanford's Malignant Hematology Fellowship Program offering clinical training and dedicated research in multiple myeloma and related plasma cell disorders, preparing fellows for academic careers.
The programme
- Focus
- Myeloma
- Training type
- Clinical + research
- Duration
- 1 year (term July 1, 2026 - June 30, 2027)
- Start
- July 1
- Positions
- Not stated on official page
- Accreditation
- Advanced (non-ACGME) fellowship; fellows appointed as Clinical Fellows in Medicine
- Department
- Not stated on official page
Eligibility and visa
- Eligibility
- Completed Medical Oncology (minimum 2 years), Hematology (minimum 2 years) or combined Hematology/Oncology (minimum 3 years) training; rarely, Internal Medicine residency graduates considered
- International applicants
- Not stated on official page
- Visa support
- Not stated on official page
- Licence requirement
- Eligible for a California medical licence
How to apply
- Deadline
- Not stated on official page
- Application method
- Letter of interest/personal statement, CV and two reference letters (one from current fellowship director) by email to the programme
Funding
- Funding
- Not stated on official page